Dietary soy protein benefit in experimental kidney disease is preserved after isoflavone depletion of diet

Experimental Biology and Medicine

Volumn 235, Issue 11, 2010, Pages 1315-1320

  Ogborn, Malcolm R ^a   Nitschmann, Evan ^a   Bankovic Calic, Neda ^a   Weiler, Hope A ^b   Aukema, Harold M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Dietary intervention; Isoflavone; Polycystic kidney disease; Rat; Saponin; Soy protein

Indexed keywords

AGLYCONE; ALCOHOL; CALCIUM; DAIDZEIN; FAT; GENISTEIN; GLYCITEIN; ISOFLAVONE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CELL PROLIFERATION; CONTROLLED STUDY; DEPLETION; DIET; DIET THERAPY; EPITHELIUM CELL; FAT CONTENT; INFLAMMATION; KIDNEY CYST; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY MASS; MALE; NONHUMAN; POST HOC ANALYSIS; RAT;

ANIMALS; CASEINS; CELL PROLIFERATION; CHOLESTEROL, LDL; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; ISOFLAVONES; MALE; ORGAN SIZE; OXIDATION-REDUCTION; POLYCYSTIC KIDNEY DISEASES; RATS; RATS, INBRED STRAINS; SOYBEAN PROTEINS;

ANIMALIA; RATTUS;

EID: 78049334600     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010059     Document Type: Article

References (45)

1. Knight EL, Stampfer MJ, Hankinson SE, Spiegelman D, Curhan GC. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 2003;138:460-7
2. Iwasaki K, Gleiser CA, Masoro EJ, McMahan CA, Seo EJ, Yu BP. The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J Gerontol 1988;43:B5-12
3. Shimokawa I, Higami Y, Hubbard GB, McMahan CA, Masoro EJ, Yu BP. Diet and the suitability of the male Fischer 344 rat as a model for aging research. J Gerontol 1993;48:B27-32
4. Williams AJ, Walls J. Metabolic consequences of differing protein diets in experimental renal disease. Eur J Clin Invest 1987;17:117-22 (Pubitemid 17060025)
5. Tomobe K, Philbrick DJ, Ogborn MR, Takahashi H, Holub BJ. Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease. Am J Kidney Dis 1998;31:55-61
6. Aukema HM, Housini I, Rawling JM. Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level. J Am Soc Nephrol 1999;10:300-8
7. Fair DE, Ogborn MR, Weiler HA, Bankovic-Calic N, Nitschmann EP, Fitzpatrick-Wong SC, Aukema HM. Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats. J Nutr 2004;134:1504-7
8. Cahill LE, Peng CY, Bankovic-Calic N, Sankaran D, Ogborn MR, Aukema HM. Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring. Br J Nutr 2007;97:77-84
9. Sankaran D, Bankovic-Calic N, Cahill L, Yu-Chen Peng C, Ogborn MR, Aukema HM. Late dietary intervention limits benefits of soy protein or flax oil in experimental polycystic kidney disease. Nephron Exp Nephrol 2007;106:e122-8
10. Friedman M, Brandon DL. Nutritional and health benefits of soy proteins. J Agric Food Chem 2001;49:1069-86
11. Cai Q, Wei H. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 1996;25:1-7
12. Kerwin SM. Soy saponins and the anticancer effects of soybeans and soy-based foods. Curr Med Chem Anticancer Agents 2004;4:263-72
13. Ogborn MR, Nitschmann E, Bankovic-Calic N, Muir A, Westcott ND, Weiler H, Aukema H. Flax and soy phytoestrogen effects on renal injury and lipid content in experimental polycystic kidney disease. J Am Nutr Assoc 2005;8:26-32
14. Coward L, Smith M, Kirk M, Barnes S. Chemical modification of isoflavones in soyfoods during cooking and processing. Am J Clin Nutr 1998;68:1486S-91S
15. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Aukema HM. Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender. Lipids 2006;41:1141-9
16. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Fitzpatrick-Wong S, Aukema HM. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease. Kidney Int 2003;64:1214-21
17. Bertin E, Ruiz JC, Mourot J, Peiniau P, Portha B. Evaluation of dual-energy X-ray absorptiometry for body-composition assessment in rats. J Nutr 1998;128:1550-4 (Pubitemid 28399955)
18. Ogborn MR, Nitschmann E, Weiler H, Leswick D, Bankovic-Calic N. Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease. Kidney Int 1999;55:417-23
19. Bosmans JL, Holvoet P, Dauwe SE, Ysebaert DK, Chapelle T, Jurgens A, Kovacic V, Van Marck EA, De Broe ME, Verpooten GA. Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years. Kidney Int 2001;59:2346-56
20. Ogborn MR, Nitschmann E, Weiler HA, Bankovic-Calic N. Modification of polycystic kidney disease and fatty acid status by soy protein diet. Kidney Int 2000;57:159-66
21. Uauy RD, Birch DG, Birch EE, Tyson JE, Hoffman DR. Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr Res 1990;28:485-92
22. Kramer JK, Fellner V, Dugan ME, Sauer FD, Mossoba MM, Yurawecz MP. Evaluating acid and base catalysts in the methylation of milk and rumen fatty acids with special emphasis on conjugated dienes and total trans fatty acids. Lipids 1997;32:1219-28
23. Ravindranath MH, Muthugounder S, Presser N, Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 2004;546:121-65 (Pubitemid 40103418)
24. McCarty MF. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses 2006;66:1093-114
25. Knapczyk K, Duda M, Szafranska B, Wolsza K, Panasiewicz G, Koziorowski M, Slomczynska M. Immunolocalisation of oestrogen receptors alpha (ERalpha) and beta (ERbeta) in porcine embryos and fetuses at different stages of gestation. Acta Vet Hung 2008;56:221-33
26. Neugarten J, Acharya A, Lei J, Silbiger S. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol Renal Physiol 2000;279:F309-18
27. Aukema HM, Housini I. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats. Kidney Int 2001;59:52-61
28. Philbrick DJ, Bureau DP, Collins FW, Holub BJ. Evidence that soyasaponin Bb retards disease progression in a murine model of polycystic kidney disease. Kidney Int 2003;63:1230-9
29. Sakemi T, Ikeda Y, Shimazu K, Uesugi T. Attenuating effect of a semipurified alcohol extract of soy protein on glomerular injury in spontaneous hypercholesterolemic male Imai rats. Am J Kidney Dis 2001;37:832-7
30. Yang HY, Chen JR, Chang LS. Effects of soy protein hydrolysate on blood pressure and angiotensin-converting enzyme activity in rats with chronic renal failure. Hypertens Res 2008;31:957-63
31. Velasquez MT, Bhathena SJ. Role of dietary soy protein in obesity. Int J Med Sci 2007;4:72-82
32. Kern M, Ellison D, Marroquin Y, Ambrose M, Mosier K. Effects of soy protein supplemented with methionine on blood lipids and adiposity of rats. Nutrition 2002;18:654-6
33. Banz WJ, Davis J, Peterson R, Iqbal MJ. Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats. Obes Res 2004;12:1907-13
34. St-Onge MP, Claps N, Wolper C, Heymsfield SB. Supplementation with soy-protein-rich foods does not enhance weight loss. J Am Diet Assoc 2007;107:500-5 (Pubitemid 46281816)
35. Bernstein AM, Treyzon L, Li Z. Are high-protein, vegetable-based diets safe for kidney function? A review of the literature. J Am Diet Assoc 2007;107:644-50
36. Soroka N, Silverberg DS, Greemland M, Birk Y, Blum M, Peer G, Iaina A. Comparison of a vegetable-based (soya) and an animal-based lowprotein diet in predialysis chronic renal failure patients. Nephron 1998;79:173-80
37. Kontessis P, Jones S, Dodds R, Trevisan R, Nosadini R, Fioretto P, Borsato M, Sacerdoti D, Viberti G. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 1990;38:136-44
38. Finco DR, Cooper TL. Soy protein increases glomerular filtration rate in dogs with normal or reduced renal function. J Nutr 2000;130:745-8
39. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 2008;31:648-54
40. Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 2003;57:1292-4 (Pubitemid 37259396)
41. Stephenson TJ, Setchell KD, Kendall CW, Jenkins DJ, Anderson JW, Fanti P. Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clin Nephrol 2005;64:1-11
42. Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP, Erdman JW Jr. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 2004;134:1874-80
43. Teixeira SR, Tappenden KA, Erdman JW Jr. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice. J Nutr 2003;133:673-8
44. Zhao JH, Sun SJ, Horiguchi H, Arao Y, Kanamori N, Kikuchi A, Oguma E, Kayama F. A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice. Int Immunopharmacol 2005;5:1601-10 (Pubitemid 41019431)
45. Anderson JW. Beneficial effects of soy protein consumption for renal function. Asia Pac J Clin Nutr 2008;17(Suppl. 1):324-8